# Nilotinib in Advanced Gastrointestinal Stromal Tumors (GIST)

> **NCT00782834** · PHASE2 · TERMINATED · sponsor: **Fox Chase Cancer Center** · enrollment: 13 (actual)

## Conditions studied

- Gastrointestinal Stromal Tumors

## Interventions

- **DRUG:** Nilotinib

## Key facts

- **NCT ID:** NCT00782834
- **Lead sponsor:** Fox Chase Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-07
- **Primary completion:** 2008-07
- **Final completion:** 2009-10
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Stopped early for futility, unable to meet accrual goals
- **Last updated:** 2013-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00782834

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00782834, "Nilotinib in Advanced Gastrointestinal Stromal Tumors (GIST)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00782834. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*